French Residential REITs Stock News

In October 2025, Teleperformance updated its earnings guidance for 2025, now expecting group like-for-like revenue growth of between 1.0% and 2.0%, lower than the previous 2% to 4% range. This downward revision follows shortly after Teleperformance was awarded a place on the Crown Commercial Services MYR 6295 framework, highlighting the company's continued expansion of its public sector services despite current growth headwinds. We'll examine how Teleperformance's revised 2025 revenue...

Schneider Electric (ENXTPA:SU) has seen some movement recently, catching the attention of investors interested in how its fundamentals stack up amid shifting market sentiment. The stock's performance over the past month offers insights that are worth a closer look. See our latest analysis for Schneider Electric. After a brief run-up earlier this year, Schneider Electric’s share price has come under pressure in recent weeks, dipping 6.2% over the last 7 days and down nearly 6% for the month...

Klépierre (ENXTPA:LI) shares have edged higher over the past month, catching some attention from investors curious about recent moves. With a history as a key player in European retail real estate, its stock performance looks intriguing. See our latest analysis for Klépierre. This recent uptick is not happening in isolation, as Klépierre’s share price has climbed 19.5% year-to-date and its one-year total shareholder return stands at an impressive 23.95%. Momentum has built steadily,...

Crédit Agricole (ENXTPA:ACA) shares have seen some movement lately, and investors are keeping an eye on how the current market environment could impact the bank’s next steps. With year-to-date returns above 17%, performance has been solid. See our latest analysis for Crédit Agricole. After a strong run earlier this year, Crédit Agricole’s share price has cooled a bit, with a 1-month return of -5.4% and a roughly flat performance in the past week. Still, momentum remains firmly positive when...

Wondering whether BNP Paribas is trading at a bargain or an overhyped price? You're in the right place, especially if you like unearthing value where others might overlook it. The stock has shown impressive long-term growth, gaining 132.1% over 5 years and 20.6% in the past year. There was a recent pullback of 13.3% over the past month. Context for these moves comes from major headlines such as BNP Paribas' strategic push into sustainable finance and its increased focus on digital banking...

Accor (ENXTPA:AC) shares have seen steady movement over the past month, gaining around 11%. Investors are curious how these gains fit within Accor’s broader strategy and outlook for the year ahead. See our latest analysis for Accor. Accor’s 11% gain over the last month caps off a period of renewed momentum, following a quieter start to the year. While the year-to-date share price return remains slightly negative, long-term holders have seen meaningful rewards, with a 6% total shareholder...

Orange (ENXTPA:ORA) stock has been relatively steady this month with small price moves. This reflects ongoing activity in the European telecom market. Investors have kept an eye on Orange’s recent results and how its growth measures are playing out. See our latest analysis for Orange. Orange’s share price has climbed steadily, with a year-to-date share price return of 46.06%. Upbeat earnings and steady demand for telecom services have helped drive this momentum. The one-year total shareholder...

Pernod Ricard recently approved board changes, a €1.2 billion bond issuance, bylaw amendments, and an annual dividend of €4.70 per share at its late October AGM. This combination of shareholder rewards, governance updates, and capital raising speaks to a period of substantial activity and engagement for the company. We'll explore how the substantial bond issuance and refreshed board composition shape Pernod Ricard's investment outlook and strategic direction. Outshine the giants: these 24...

Legrand SA recently confirmed its full-year 2025 earnings guidance, projecting sales growth of 10% to 12% excluding currency effects, and reported nine-month sales of €6.97 billion with net income of €892.3 million. While the company highlighted ongoing growth and a positive outlook for data centres, attention has shifted to softer demand trends and the timing of future growth as quarterly sales growth missed some analyst expectations. We'll examine how Legrand's reaffirmed sales guidance...

The Clariane SE ( EPA:CLARI ) share price has fared very poorly over the last month, falling by a substantial 26...

Danone (ENXTPA:BN) shares have edged up around 1% in the past day, building on a nearly 8% rise over the past month. Investors appear to be weighing steady gains against broader sector trends, with recent price action reflecting a calm and measured outlook. See our latest analysis for Danone. After a simmering stretch, Danone's recent share price gains are adding to a strong year-to-date run, with momentum now picking up pace. The stock has notched a 21% share price return since January, and...

Wondering if Capgemini's stock offers hidden value or if recent market trends have changed the story? You're in the right place to get a clear perspective. Capgemini's share price has seen sharp swings lately, dropping 7.6% over the past week but managing to notch a modest 1.1% gain over the last month and a 17.4% return over five years. This points to both volatility and longer-term potential. Recent headlines have spotlighted Capgemini's strategic acquisitions and fresh partnerships in the...

Eurofins Scientific (ENXTPA:ERF) shares have been fluctuating recently, prompting investors to reassess their views on the stock’s prospects over the coming months. There has not been a major single event sparking the latest moves. See our latest analysis for Eurofins Scientific. Eurofins Scientific’s share price has seen some turbulence lately, with a notable drop in the past month. However, looking at the bigger picture, the stock is still showing strong momentum year-to-date with a 19.5%...

Ever wondered if Sanofi stock is genuinely undervalued or just flying under the radar? Let’s break down what’s really happening beneath the surface so you can decide with confidence. Sanofi’s share price has slipped by 2.5% over the past week, but it has seen a mild rebound of 1.0% over the last month, amidst a longer-term dip of 9.4% year-to-date. Recent headlines have centered on Sanofi’s steps to advance its drug pipeline, as well as strategic moves in partnerships and market expansion...

Wondering if Teleperformance is a hidden gem or if its recent prices are too risky? You are not alone, as many investors are scanning for undervalued stocks in today’s market. The share price is down by 2.6% over the last week, and it has lost 35.7% over the past year. This has understandably caught the attention of both bargain hunters and cautious investors. Much of that volatility comes in the wake of fresh regulatory concerns and management changes. These factors have been widely...

Pluxee (ENXTPA:PLX) has seen its stock performance shift over the past month, rising around 3% despite recent declines. Investors are watching closely for any signals in the company's financial health or strategy that could explain these moves. See our latest analysis for Pluxee. Zooming out, Pluxee’s swift 1-day share price return of -5.26% follows a much softer month. A 1-month share price return of 2.7% hints at regained momentum after earlier declines. Despite recent volatility, the stock...

As the European market navigates a landscape of mixed stock index performances and steady interest rates from the European Central Bank, investors are keenly observing opportunities for stable returns amid these fluctuating conditions. In this context, dividend stocks can offer a compelling option for those looking to enhance their portfolios with reliable income streams.

Legrand (ENXTPA:LR) just confirmed its full-year 2025 sales guidance, expecting 10% to 12% growth excluding currency effects. This comes after the release of their latest earnings, which showed year-over-year increases in both sales and net income. See our latest analysis for Legrand. Despite Legrand's upbeat 2025 outlook and encouraging earnings growth, the share price recently slid 12.19% in a single day and is down nearly 13% for the week. Strong year-to-date momentum remains intact,...

Viridien Société anonyme's ( EPA:VIRI ) strong earnings report was rewarded with a positive stock price move. We have...

Wondering if Vallourec stock is undervalued or primed to soar further? You are not alone, as plenty of investors are taking a closer look at what sets this company apart from its sector peers. The stock has delivered a 15.3% return over the last year, with some volatility along the way. It is up 3.3% over the past week but down 3.3% in the last month. Recent headlines have spotlighted Vallourec's strategic expansion into new markets and renewed contracts with major energy players. These...

Curious whether Veolia Environnement is a hidden gem or already fully priced? Let’s break down what savvy investors are seeing in this global utilities player. The stock has edged up by 0.6% in the past week and has climbed 8.1% year-to-date. Over five years, it has posted an impressive 100.1% gain. These moves indicate both opportunity and shifting market sentiment. Recent headlines have centered around Veolia’s ambitious sustainability initiatives, including new circular economy...

X-FAB Silicon Foundries (ENXTPA:XFAB) is drawing investor focus after announcing CEO Rudi De Winter will step down in February 2026, with COO Damien Macq set to take the helm. The news comes alongside fresh quarterly earnings and revised guidance. See our latest analysis for X-FAB Silicon Foundries. X-FAB Silicon Foundries’ latest earnings and leadership shakeup have certainly caught the market's eye, but momentum has turned sharply negative, with a 30-day share price return of -33.4%...

Last week, you might have seen that COFACE SA ( EPA:COFA ) released its quarterly result to the market. The early...

If you have ever wondered whether Eurofins Scientific is a good buy right now, you are not alone. Questions of value have been swirling as more investors focus on the stock's potential. After climbing 32.0% over the past year (and up 21.1% so far this year), the share price has pulled back by 5.0% in the last month. This shift hints at changing dynamics between growth optimism and risk. Recent headlines have highlighted Eurofins’ expansion into new diagnostic technologies and strategic...